SEC Tracker
Get the app

Aibotics AIBT

Aibotics acquires Empulser

Form
8-K
Filed
Importance
Routine
  1. Enters into stock exchange agreement with Empulser
  2. Issues up to $22M in Series C Preferred Stock
  3. Earn-out based on milestones over 36 months
  4. Empulser becomes wholly owned subsidiary

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Aibotics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2833 and related industry codes: the same peer list as the financial tables.

  1. Agentix AGTX public float $1M, Sep 30, 2025
  2. Galera Therapeutics GRTX public float $2M, Jun 30, 2025
  3. ProtoKinetix PKTX public float $2M, Jun 30, 2026
  4. Evofem Biosciences EVFM public float $1M, Jun 30, 2025
  5. Regen BioPharma RGBP public float $1M, Mar 31, 2025, over 18 months old